XYDRII
Live / Registered — Registered (as of 10 Nov 2020)
What this means for you
Registered since 10 Nov 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79284840
- Registration number
- 6192259
- Mark type
- Stylized text
- Filed
- 16 Mar 2020
- Published for opposition
- 30 Jun 2020
- Registered
- 10 Nov 2020
- Attorney of record
- Nancy L. Rowe
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all of the foregoing excluding pharmaceutical preparations for the treatment or prevention of neurological disorders, sleep disorders, and central nervous system
Owner
- Bausch + Lomb Ireland Limited, IE
- NOVARTIS AG, CH
- NOVARTIS AG, CH
- NOVARTIS AG, CH
Prosecution history
- 10 Nov 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 10 May 2024 — CHANGE OF OWNER RECEIVED FROM IB
- 17 Mar 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Mar 2024 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
- 17 Mar 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Mar 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 17 Mar 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 17 Mar 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 08 Jan 2021 — NOTIFICATION PROCESSED BY IB
- 18 Dec 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 17 Dec 2020 — FINAL DISPOSITION PROCESSED
- 10 Dec 2020 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
- 10 Nov 2020 — REGISTERED-PRINCIPAL REGISTER
- 08 Oct 2020 — POST PUBLICATION AMENDMENT - ENTERED
- 06 Oct 2020 — ASSIGNED TO PETITION STAFF